Jiao Dechao,Han Xinwei,Wang Junjie,Zhang Jianhao,Wang Yanli,Shui Shaofeng,Ren Jianzhuang,Li Zongming,Zhang Quanhui,Niu Rongfang.Preliminary experience of 125Ⅰ seed strands cavity brachytherapy for ureteral carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2017,37(7):508-513
Preliminary experience of 125Ⅰ seed strands cavity brachytherapy for ureteral carcinoma
Received:March 14, 2017  
DOI:10.3760/cma.j.issn.0254-5098.2017.07.007
KeyWords:125Ⅰ seed strands  Brachytherapy  Ureteral carcinoma
FundProject:国家高新研发项目(863项目)(2015AA020301)
Author NameAffiliationE-mail
Jiao Dechao Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Han Xinwei Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China 13592583911@163.com 
Wang Junjie Department of Radiation Oncology, Third Hospital of Peking University  
Zhang Jianhao Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Wang Yanli Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Shui Shaofeng Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Ren Jianzhuang Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Li Zongming Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Zhang Quanhui Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Niu Rongfang Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China  
Hits: 2328
Download times: 2094
Abstract::
      Objective To evaluate the safety and efficacy of 125Ⅰ seed strands cavity brachytherapy for ureteral carcinoma. Methods To tally 10 patients with ureteral carcinoma underwent C-arm CT and DSA guided percutaneous nephrostomy with 125Ⅰ seed strands cavity brachytherapy. The technical success rate, complications, tumor local control rate, ureteral patency andsurvival time, and compared the Karnofsky scores, Girignon grade, pain score before and after treatment were evaluated.The dose related parameters were compared between pre-and post-treatment. Results 125Ⅰ seed strands implantation was successfully completed in all patients with technical success rate of 100%. The mean procedure time was (12.3±3.8) min. No severe complications such as ureteral perforation, infection, severe bleeding occurred. Local tumor response was CR in 4 cases and PR in 6 cases, showing local control efficiency (CR+PR) 100% after 2-3 months. Ureteral patency rate was 50% (5/10). Postprocedure Karnofsky scores, Girignon grades, and pain scores were significantly improved (Z=-2.72, -2.88, -2.83, P<0.01). The average follow-up time was (14.6±6.5) months (5-25 months), tumor progression was observed in 3 cases, stable disease in 7 cases. Nine cases were alive and one died due to multiple organ failure. The differences of D90%, mPD, V100%, V150%, V200%, CI, EI, HI between the pre-and post-treatment were not statistically significant (P>0.05). Conclusions 125Ⅰ seed strands cavity brachytherapy for ureteral carcinoma is an effective and safe procedure without serious complications, and an effective alternative treatment for patients who are unable to undergoor refuse surgery.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:9062872  On-line:0

v
Scan QR Code
&et=05856B6FACD30C99B7CCDEA4FAEA3F87E95676A5DBB1581C2FAA07FB409679B207A1D5038124054A060A1AFA3DF66F8FF1E2E534699E35013C6DC4EECE1AAE7670F73472D52C4EEDA65C2D68F74F835E9DF09880A26C38799A9309AC01525004B770D978B2E7AC55&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FA004A8A4ED1540B&aid=BF88AFC87C5C19B4E88739757777ACCB&vid=&iid=DF92D298D3FF1E6E&sid=37F781FD8E744761&eid=F9A6B6F259CE5121&fileno=20170707&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FA004A8A4ED1540B"; var my_aid="BF88AFC87C5C19B4E88739757777ACCB";